lerner.ccf.org:

New research points to inflammation within the brain as a critical contributor to neuronal abnormalities leading to Alzheimer’s disease (AD) and suggests that early and prolonged treatment with common nonsteroidal anti-inflammatory drugs (NSAIDs) could block this inflammation before the disease establishes itself.

>> weiterlesen… (zum Originalartikel)